Navigation Links
American Pacific to Release Financial Results and Hold Fiscal 2008 Third Quarter Investor Teleconference

LAS VEGAS, July 29 /PRNewswire-FirstCall/ -- American Pacific Corporation (Nasdaq: APFC) today announced that it will release its Fiscal 2008 third quarter financial results on Tuesday, August 5, 2008. John R. Gibson, Chairman and Chief Executive Officer, invites you to participate in a teleconference to review the financial results and outlook of the Company.

The teleconference will be held Tuesday, August 5, 2008 at 1:30 p.m. PDT. To access the call please dial (973) 582-2852 and reference conference ID #58118598. Following a short presentation by Mr. Gibson and Dana M. Kelley, Vice President, Chief Financial Officer and Treasurer, there will be a Q&A session. Also present on the call will be Joseph Carleone, President and Chief Operating Officer.

The teleconference will be simultaneously webcast via Thomson Financial's First Call Events. A link to the live webcast will be available at the Company's website at and will remain available for replay through December 2008.

American Pacific is a leading manufacturer of specialty and fine chemicals within its focused markets, as well as propulsion products sold to defense, aerospace and pharmaceutical end markets. Our products provide access to, and movement in, space via solid fuel and propulsion thrusters and represent the key active ingredient in drug applications such as HIV, epilepsy and cancer. We also produce specialty chemicals utilized in various applications such as fire extinguishing systems, as well as manufacture water treatment equipment. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about American Pacific can be obtained by visiting the Company's web site at

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
2. American Oriental Bioengineering, Inc. to Report Second Quarter 2008 Financial Results
3. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
4. American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes
5. American Telugu Association's Convention Attracts Over 10,000 People in the U.S.
6. Covert Torture, Surveillance Jeopardizes the Freedom of American Citizens
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
9. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
10. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
11. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):